---
document_datetime: 2023-09-21 20:34:30
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/pemetrexed-pfizer-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: pemetrexed-pfizer-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6294031
conversion_datetime: 2025-12-24 20:16:36.078896
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Pemetrexed Pfizer

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|------------------------------------------|----------------------------------|-----------|
| IB/0008              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 28/05/2019                          | product                                  | SmPC and PL                      |           |
| N/0007               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 09/04/2019                          |                                          | PL                               |           |

<!-- image -->

<!-- image -->

Medicinal product no longer authorised

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0006     | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                  | 20/03/2019         | n/a authorised                       |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|--------------------------------------|
| IAIN/0005/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 12/12/2018         | Annex II and longer                  |
| T/0004      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                     | 12/09/2018         | 28/09/2018 SmPC, Labelling and no    |
| IA/0003     | A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs                                                                                                                                                                                                                                                         | 27/08/2018 product | PL 28/09/2018 SmPC, Labelling and PL |
| IAIN/0002   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                          | 24/04/2018         | 28/09/2018 SmPC and                  |
| N/0001      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                        | 20/11/2017         | 28/09/2018 PL                        |